Astrazeneca

Latest Stories

James Teague, president of AstraZeneca's in Thailand attends a signing ceremony at Government House in Bangkok, Thailand Friday, Nov. 27, 2020. Thailand on Friday signed a deal to procure 26 million doses of the trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. (Chalinee Thirasupa/Pool Photo via AP)

Thailand, Philippines sign for AstraZeneca COVID-19 vaccine

By CHALIDA EKVITTHAYAVECHNUKUL - Associated Press

Doctors and nurses attend to a patient at the intensive care unit for COVID-19 patients in the Andras Josa hospital in Nyiregyhaza, Hungary, Thursday, Nov. 26, 2020 (Attila Balazs/MTI via AP).

The Latest: Illinois surpasses 12,000 deaths from COVID-19

By The Associated Press - Associated Press

In this undated file photo issued by the University of Oxford on Monday, Nov. 23, 2020, a researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University. With major COVID-19 vaccines showing high levels of protection, British officials are cautiously — and they stress cautiously — optimistic that life may start returning to normal by early April. (University of Oxford/John Cairns via AP, File)

AstraZeneca vaccine to be assessed amid dosing error questions

By Jill Lawless - Associated Press

A currency trader watches monitors at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Friday, Nov. 27, 2020. Asian stock markets declined Friday as questions about the effectiveness of one possible coronavirus vaccine weighed on investor optimism. (AP Photo/Ahn Young-joon)

Asian stocks fall amid unease about vaccine development

By JOE McDONALD - Associated Press

UK asks regulator to assess AZ-Oxford vaccine amid questions

By JILL LAWLESS - Associated Press

AstraZeneca manufacturing error clouds vaccine study results

By DANICA KIRKA - Associated Press

Editorial Roundup: West Virginia

By The Associated Press - Associated Press

This Thursday, April 23, 2020, file screen grab taken from video issued by Britain's Oxford University shows a person being injected as part of the first human trials in the U.K. to test a potential coronavirus vaccine, untaken by Oxford University in England. AstraZeneca says late-stage trials of its COVID-19 vaccine were “highly effective’’ in preventing disease. A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, the team reported Monday, Nov. 23, 2020. (Oxford University Pool via AP, File)

AstraZeneca reports promising results from coronavirus vaccine trial

By Tom Howell Jr. - The Washington Times

In this Wednesday, June 24, 2020, file photo, a volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa's first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. On Friday, Oct. 23, 2020, AstraZeneca Inc. announced that the Food and Drug Administration is letting it resume testing of its COVID-19 vaccine candidate in the U.S. (Siphiwe Sibeko/Pool via AP)

AstraZeneca: COVID-19 vaccine ‘highly effective’ prevention

By Danica Kirka and Jill Lawless - Associated Press

FILE - Officials sort ballots during an audit at the Floyd County administration building in Rome, Ga. on Friday morning, Nov. 13, 2020. On Friday, Nov. 20, The Associated Press reported on stories circulating online incorrectly asserting that the identities of deceased residents in Georgia were used to illegally cast ballots in the 2020 presidential election. (AP Photo/Ben Gray, File)

NOT REAL NEWS: A look at what didn’t happen this week

By The Associated Press - Associated Press

AstraZeneca, Oxford vaccine produces strong immune response

By Shen Wu Tan - The Washington Times

A mannequin wears a face mask in front of outdoor seating at the Wipeout Bar and Grill at Pier 39 during the coronavirus outbreak in San Francisco, Thursday, Nov. 12, 2020. (AP Photo/Jeff Chiu)

Coronavirus spread in U.S. alarms officials as Americans grow weary of limits

By Tom Howell Jr. - The Washington Times

President Donald Trump speaks in the Rose Garden of the White House, Friday, Nov. 13, 2020, in Washington. (AP Photo/Evan Vucci)

Trump takes victory lap on coronavirus vaccine, says New York will have to wait for doses

By Tom Howell Jr. - The Washington Times

In this Wednesday, June 24, 2020, file photo, a volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa's first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. On Friday, Oct. 23, 2020, AstraZeneca Inc. announced that the Food and Drug Administration is letting it resume testing of its COVID-19 vaccine candidate in the U.S. (Siphiwe Sibeko/Pool via AP)

AstraZeneca to deliver vaccine trial data by year’s end

By DANICA KIRKA - Associated Press

A masked woman holds a Winnie the Pooh inflatable balloon, inside the subway, in Paris, Thursday Oct.29, 2020. Some doctors expressed relief but business owners despaired as France prepared to shut down again for a month to try to put the brakes on the fast-moving virus. (AP Photo/Lewis Joly)

The Latest: Kentucky sees near-record number of new cases

By The Associated Press - Associated Press

Brazil approves import of Chinese shot that Bolsonaro nixed

By CHRISTIANA SCIAUDONE - Associated Press

In this Wednesday, June 24, 2020, file photo, a volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa's first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. On Friday, Oct. 23, 2020, AstraZeneca Inc. announced that the Food and Drug Administration is letting it resume testing of its COVID-19 vaccine candidate in the U.S. (Siphiwe Sibeko/Pool via AP)

AstraZeneca, J&J resuming US tests of COVID-19 vaccines

By LINDA A. JOHNSON - Associated Press

Brazil's President Jair Bolsonaro listens during a presentation at the Planalto Presidential Palace in Brasilia, Brazil, Monday, Oct. 19, 2020. The Brazilian government announced the results of clinical tests with use of the drug Nitazoxanide for COVID-19 treatment. (AP Photo/Eraldo Peres)

Brazil’s Bolsonaro rejects Chinese vaccine against COVID-19

By MAURICIO SAVARESE - Associated Press

This September 2020 photo provided by Johnson &amp; Johnson shows a single-dose COVID-19 vaccine being developed by the company. A late-stage study of Johnson &amp; Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot, the company announced Monday, Oct. 12, 2020. (Cheryl Gerber/Courtesy of Johnson &amp; Johnson via AP, File)

Johnson & Johnson COVID-19 vaccine pause due to ‘unexplained illness’

Associated Press

This September 2020 photo provided by Johnson &amp; Johnson shows a single-dose COVID-19 vaccine being developed by the company. A late-stage study of Johnson &amp; Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot, the company announced Monday, Oct. 12, 2020. (Cheryl Gerber/Courtesy of Johnson &amp; Johnson via AP, File)

2nd COVID-19 vaccine trial paused over unexplained illness

Associated Press